CEL-SCI closes $5M public offering of 2M shares at $2.50/share for Multikine development

CEL SCI CORP

Gross proceeds $5M from 2M shares at $2.50; underwriting discount $0.175 per share.
Underwriters have 45-day over-allotment option for up to 190K additional shares.
Net proceeds to fund continued Multikine development, general corporate, and working capital.
Offering closed May 23, 2025; ThinkEquity acted as sole book-running manager.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.